<DOC>
	<DOCNO>NCT00004694</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine safety efficacy inhale subcutaneously administer heparin treatment hereditary angioedema .</brief_summary>
	<brief_title>Study Heparin Prophylaxis Hereditary Angioedema Exacerbations</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo control , 3 way crossover study . All patient complete diary card first month study order determine compliance provide daily record symptom medication take . All compliant patient receive subcutaneously inject heparin twice daily , inhale heparin daily , match saline placebo random order . Each three drug administration period last 2 month , total 6 month treatment . Patients flare disease activity require hospitalization terminate drug administration period study . Patients follow biweekly first month end second month three 2 month drug administration period . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angioedemas , Hereditary</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Confirmed diagnosis hereditary angioedema ( HAE ) base upon C4 antigenic level , positive family history , C1 inhibitor ( C1INH ) antigenic level ( Type I HAE ) functional level ( Type II HAE ) Functional C1 within normal level diagnosis acquire C1INH possible Negative family history exclude long patient meet criterion , normal C1 level , evidence acquire C1INH deficiency History symptom HAE include episodic swelling , abdominal pain , and/or respiratory difficulty Experiencing minimum 12 HAE episode within 6 week Prior/Concurrent Therapy Endocrine therapy : Anabolic steroid allow long dose change least 30 day Other : No concurrent least 1 week since prior aspirin , nonsteroidal antiinflammatory agent , dipyridamole , Coumadinlike drug , medication effect coagulation platelet Patient Characteristics Hematopoietic : No clinically significant history hematologic disease Hepatic : No clinically significant history hepatic disease Renal : No clinically significant history renal disease Cardiovascular : No clinically significant history cardiac disease hypertension Pulmonary : No clinically significant history pulmonary disease Other : No contraindication use inhale subcutaneous heparin No drug allergy would interfere study No clinically significant history : Malignancy Diabetes mellitus Neurologic disease Immunologic disease Bleeding disorder Infirmity No history drug abuse , alcoholism , psychosis , psychological/psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1999</verification_date>
	<keyword>genetic disease dysmorphic syndrome</keyword>
	<keyword>hereditary angioedema</keyword>
	<keyword>rare disease</keyword>
</DOC>